C.R. Bard (BCR) : The money flow analysis of C.R. Bard (BCR) indicates a $10.69 million of outflow was on downticks, whereas, the investors on Thursday gobbled up stocks worth $16.2 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.51 and so was the total money flow at $5.51 million. The bulls lapped up $4.72 million worth of block trades on upticks. The money flow was $4.72 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of C.R. Bard (BCR), pushing it down by -0.08% for the day. The stock slid $0.18 and traded at $234.34 during the day. Nonetheless, the stock is -1.95% over the previous weeks close.
The stock has recorded a 20-day Moving Average of 1.49% and the 50-Day Moving Average is 4.53%. Shares have rallied 33.09% from its 1 Year high price. On Jul 11, 2016, the shares registered one year high at $239.43 and the one year low was seen on Jan 15, 2016. The 50-Day Moving Average price is $226.82 and the 200 Day Moving Average price is recorded at $204.31.
C.R. Bard (NYSE:BCR): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $235.53 and $234.27 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $236.17. The buying momentum continued till the end and the stock did not give up its gains. It closed at $234.90, notching a gain of 0.16% for the day. The total traded volume was 411,206 . The stock had closed at $234.52 on the previous day.
In an insider trading activity, Holland Christopher S, officer (Senior Vice President and CFO) of Bard C R Inc /Nj/, unloaded 3,970 shares at an average price of $219.88 on May 27, 2016. The total amount of the transaction was worth $872,924, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.